Schedule of Events

Luncheon Sessions

Monday, May 7, 2007

12:30 PM - 2:00 PM
Vista Ballroom
Sponsored by Burrill & Company

State of the Biotechnology Industry

2005 has been an exciting year for the biotech industry not withstanding the U.S. and world economies being less than robust. The capital markets dramatically improved forthe biotech industry, and IPOs have returned, driven by powerful new genomics and other enabling technologies that are changing both drug discovery and development . . . and leading us toward both personalized medicine and a move to more predictability and ultimately to preventative medicine (the treatment of wellness). Regulatory development (especially in this post-Vioxx world), product approvals, product success in the marketplace, and mergers have changed the landscape for biotech dramatically. G. Steven Burrill's annual analysis of the "State of the Industry" has been an important part of the biotech industry's view of itself over the last 20 years. Biotech 2006, a perspective on where the industry has been and is going, will be the focus of this talk.

G. Steven Burrill, CEO, Burrill & Company

Open to all full conference registrants and Monday-only full registrants. Seating will be on a first-come, first-served basis.